JMKX003142 will be administered orally

DRUG2 trials

Sponsors

Jemincare

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)Safety and Tolerability

Phase 1

Phase 1 Clinical Study of JMKX003142 Tablets

JemincareSafety and Tolerability

Start: 2023-07-06End: 2025-03-30Target: 106Updated: 2023-10-17

Phase 2

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

RecruitingNCT06800651

JemincareADPKD (Autosomal Dominant Polycystic Kidney Disease)

Start: 2025-03-13End: 2027-05-30Target: 135Updated: 2025-07-03